Evidence map›Paper›PMID 36517394›Full record

ArticleClinical genitourinary cancer2023

The Impact of Covid-19 Pandemic on Genitourinary Cancers Stage and Grade.

Diana Taheri, Fatemeh Jahanshahi, Alireza Khajavi, Fatemeh Kafi, Alireza Pouramini, Reza M Farsani, Yasamin Alizadeh, Maryam Akbarzadeh, Leonardo O Reis, Fatemeh Khatami and 1 more

Open access · greenAbstract read
In one paragraph

Article in Clinical genitourinary cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Diana TaheriIsfahan Kidney Disease Research Center, Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran; Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Fatemeh JahanshahiUrology Research Center, Tehran University of Medical Sciences, Tehran, Iran; Research Committee Member, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Alireza KhajaviStudent Research Committee, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fatemeh KafiUrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Alireza PouraminiUrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Reza M FarsaniUrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Yasamin AlizadehDepartment of Pathology, Moheb-Mehr Hospital, Tehran, Iran.
Maryam AkbarzadehDepartment of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, the Netherlands.
Leonardo O ReisUroScience and Department of Surgery (Urology), School of Medical Sciences, University of Campinas, Unicamp, and Pontifical Catholic University of Campinas, PUC-Campinas, Campinas, São Paulo, Brazil.
Fatemeh KhatamiUrology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Seyed Mohammad Kazem AghamirUrology Research Center, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: mkaghamir@tums.ac.ir.
Tehran University of Medical Sciences · IRErasmus MC Cancer Institute · NLIran University of Medical Sciences · IRIsfahan University of Medical Sciences · IRShahid Beheshti University of Medical Sciences · IRUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionOur study aims to evaluate the impact of the COVID-19 pandemic on the number of uro-oncological surgeries (cystectomy, nephrectomy, prostatectomy, orchiectomy, and transurethral resection of bladder tumor (TURBT)) and pathological staging and grading. MATERIALS AND

methodsThe present study is a retrospective study on patients with genitourinary cancers treated from 2018 to 2021 in a referral tertiary center. The data were obtained from the hospital records with lengths of 22 and 23 months, labeled hereafter as non-COVID and COVID pandemic, respectively (2018/3/21-2020/1/20 and 2020/1/21-2021/12/21). The total number of registered patients, gender, age, stage, and grade were compared in the targeted periods. Moreover, all the pathologic slides were reviewed by an expert uropathologist before enrolling in the study. The continuous and discrete variables are reported as mean (standard deviation (SD)) and number (percent) and the χ

resultsIn this study total number of 2077 patients were enrolled. The number of procedures performed decreased during the Covid pandemic. The tumors' distribution stage and grade and patients' baseline characteristics were not significantly different in non-COVID and COVID pandemic periods for Radical Nephrectomy, Radical Cystectomy, Radical Prostatectomy, and orchiectomy. For TURBT only, the tumor stage was significantly different (P-value<.001) from the higher stages in the COVID pandemic period.

conclusionAmong urinary tract cancers, staging of bladder cancer and TURBT are mainly impacted by the COVID-19 pandemic with higher stages compared to the non-COVID period. We evaluate the impact of the COVID-19 pandemic on the number of uro-oncological surgeries based on pathological staging and grading. Total number of 2077 patients were enrolled. Among urinary tract cancers, staging of bladder cancer and TURBT are mainly impacted by the COVID-19 pandemic with higher stages compared to the non-COVID period.

Indexed as

COVID-19Urinary Bladder NeoplasmsUrologic NeoplasmsCystectomyHumansMalePandemicsRetrospective StudiesCOVID-19 pandemicCystectomyNephrectomyOrchiectomyProstatectomyTURBT

Identifiers

PMID36517394
PMCPMC9684093
OpenAlexW4310075633

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.